Epigenetic clocks in relapse after a first episode of schizophrenia
-
Published:2022-07-22
Issue:1
Volume:8
Page:
-
ISSN:2754-6993
-
Container-title:Schizophrenia
-
language:en
-
Short-container-title:Schizophr
Author:
Segura Àlex-González, Prohens Llucia, Mezquida Gisela, Amoretti SilviaORCID, Bioque Miquel, Ribeiro María, Gurriarán-Bas Xaquin, Rementería Lide, Berge Daniel, Rodriguez-Jimenez Roberto, Roldán Alexandra, Pomarol-Clotet Edith, Ibáñez Angela, Usall Judith, García-Portilla Maria PazORCID, Cuesta Manuel J., Parellada Mara, González-Pinto Ana, Berrocoso EstherORCID, Bernardo MiquelORCID, Mas SergiORCID, González-Díaz Jairo M., Arbelo Néstor, González-Peñas Javier, Pina-Camacho Laura, Diestre Alba, Selma Judit, Zorrilla Iñaki, López Purificación, Trabsa Amira, Monserrat Clara, Sanchez-Pastor Luis, Nuñez-Doyle Aggie, Fatjó-Vilas Mar, Sarró Salvador, Butjosa Anna, Pardo Marta, López-Ilundain Jose M., Sánchez Torres Ana M., Saiz-Ruiz Jerónimo, Ochoa-Mangado Enriqueta, RIevero Olga, De-la-Cámara Concepción, Echevarría Rafael Segarra, González-Blanco Leticia,
Abstract
AbstractThe main objective of the present study was to investigate the association between several epigenetic clocks, covering different aspects of aging, with schizophrenia relapse evaluated over a 3-year follow-up period in a cohort of ninety-one first-episode schizophrenia patients. Genome-wide DNA methylation was profiled and four epigenetic clocks, including epigenetic clocks of chronological age, mortality and telomere length were calculated. Patients that relapsed during the follow-up showed epigenetic acceleration of the telomere length clock (p = 0.030). Shorter telomere length was associated with cognitive performance (working memory, r = 0.31 p = 0.015; verbal fluency, r = 0.28 p = 0.028), but no direct effect of cognitive function or symptom severity on relapse was detected. The results of the present study suggest that epigenetic age acceleration could be involved in the clinical course of schizophrenia and could be a useful marker of relapse when measured in remission stages.
Funder
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Garcia-Rizo, C., Fernandez-Egea, E., Bernardo, M. & Kirkpatrick, B. The thrifty psychiatric phenotype. Acta Psychiatr. Scand. 131, 18–20 (2015). 2. Nordentoft, M. et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS ONE 8, e55176 (2013). 3. Saha, S., Chant, D. & Mcgrath, J. A systematic review of mortality in schizophrenia is the differential mortality gap worsening over time? Population-based studies that re-ported primary data on deaths in people with schizo-phrenia. Arch. Gen. Psychiatry 64, 1123–1131 (2007). 4. Momen, N. C. et al. Mortality associated with mental disorders and comorbid general medical conditions. JAMA Psychiatry (2022) https://doi.org/10.1001/JAMAPSYCHIATRY.2022.0347. 5. Kirkpatrick, B., Messias, E., Harvey, P. D., Fernandez-Egea, E. & Bowie, C. R. Is schizophrenia a syndrome of accelerated aging? Schizophr. Bull 34, 1024–1032 (2008).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|